Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3C9MX
|
|||
| Drug Name |
JNJ-63682918
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human papillomavirus infection [ICD-11: 1A9Y; ICD-9: 078.1079.4] | Phase 1/2 | [1] | |
| Company |
Janssen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03610581) Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.